Among the most dependable areas of healthcare investment stands the global T Cell Therapy market within the medical device industry, with the greatest transformative capacity for expansion and innovation. A modern healthcare setup reflects advances in the equipment to enable quick treatments and pinpoint accuracy in results. The global T Cell Therapy market shall see a 29.0% between 2025 and...
The global CAR T-cell therapy market size was estimated at USD 5.82 billion in 2025 and is projected to reach USD 22.36 billion by 2033, expanding at a CAGR of 18.06% from 2026 to 2033. Market expansion is primarily supported by the growing global cancer burden, increasing adoption of personalized and cell-based immunotherapies, advancements in gene-editing technologies, and favorable...
CAR T-cell Therapy is one of the most advanced forms of immunotherapy used to treat certain types of cancer, especially blood cancers such as leukemia, lymphoma, and multiple myeloma. This therapy works by modifying a patient’s own immune cells (T cells) in a laboratory so they can recognize and attack cancer cells more effectively. Once engineered, these cells are infused back into the...
Evolving Landscape of Cell & Gene Therapy CDMOs
The global cell and gene therapy CDMO market is undergoing rapid transformation, driven by the increasing complexity of advanced therapeutics and the growing reliance on outsourcing. A biopharmaceutical CDMO today is no longer limited to traditional manufacturing; it has evolved into a strategic partner offering end-to-end CDMO services, from...
According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031.
Graft versus Host Disease, a serious complication following stem cell or bone...
Advancing the Next Generation of Personalized Medicine
Cell therapy technologies are rapidly reshaping modern healthcare by enabling treatments that address disease at a cellular level rather than merely managing symptoms. Over the past few years, progress in biotechnology, genomics, and manufacturing has accelerated the development of cell-based therapies, opening new possibilities for...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt